Virginia Tech
Investigation of Advanced Cavitation Agents for Nanoparticle-Mediated Histotripsy (NMH) Applications
Abstract
dc:description.abstractNanoparticle-mediated histotripsy (NMH) is an emerging non-invasive therapy that combines focused ultrasound with engineered nanoparticles to induce controlled acoustic cavitation for the mechanical ablation of targeted tissues. Unlike conventional histotripsy, which relies on endogenous cavitation nuclei and typically requires high negative pressure (>25 MPa), NMH utilizes nanoparticles to initiate cavitation at significantly lower pressures (<15 MPa). This lower threshold not only improves the safety and precision of the therapy but also expands its potential applications across a broader range of tissue types and anatomical sites. As a versatile and tunable platform, NMH offers the ability to integrate multifunctional nanoparticles that enable synergistic capabilities, such as targeted ablation or localized drug delivery, all within a single treatment modality. To date, NMH has demonstrated proof-of-concept success in applications such as prostate cancer ablation and catheter-based biofilm removal. However, its full potential as a multifunctional therapeutic platform for more complex disease environments remains underexplored. In this dissertation, I investigate the feasibility and optimization of NMH for two clinically relevant and challenging scenarios: the treatment of breast cancer and the eradication of biomaterial-associated infections. Specifically, this work focuses on: (1) the characterization of NMH cavitation agents with clinically relevant pulsing parameters, (2) the feasibility of NMH as a breast cancer treatment, and (3) the characterization and feasibility of dual-function NMH cavitation agents for the treatment of breast cancer and biomaterial-associated infections. Through this research, I demonstrate how NMH can be strategically tuned to meet the demands of different clinical presentations by adjusting both the physicochemical properties of the nanoparticles and the acoustic protocols used for treatment. This work will establish NMH as a flexible, precise, and multi-functional treatment platform. Ultimately, this dissertation contributes to the development of a next-generation therapeutic approach that bridges the gap between mechanical ablation and drug delivery, all enabled through nanoparticle-mediated cavitation.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Biomedical Engineering
- Department dc:contributor.department
- Department of Biomedical Engineering and Mechanics
- Grantor dc:publisher
- Virginia Tech
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Hall, Sarah Louella
- Chair dc:contributor.committeechair
-
- Vlaisavljevich, Eli
- Committee members dc:contributor.committeemember
-
- Allen, Irving C.
- Sheybani, Natasha
- Durmaz, Yasemin
- Munson, Jennifer M.
Subjects
dc:subject × 5Rights
dc:rights- Statement dc:rights
-
- In Copyright
- Licence dc:rights.uri
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Dc Identifier Other
- vt_gsexam:43562